Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.
作者信息
Ahmed S R, Shalet S M, Grant J, Howell A, Blacklock N J
出版信息
Br Med J (Clin Res Ed). 1984 Sep 29;289(6448):831. doi: 10.1136/bmj.289.6448.831-b.
Abstract
摘要
相似文献
1
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.长期使用促黄体生成素释放激素治疗前列腺癌未能抑制血清促黄体生成素和睾酮。
Br Med J (Clin Res Ed). 1984 Sep 29;289(6448):831. doi: 10.1136/bmj.289.6448.831-b.
2
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.用于前列腺癌的可生物降解聚合物促黄体生成素释放激素类似物：一种新型肽递送系统的应用
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1580-1. doi: 10.1136/bmj.289.6458.1580.
3
Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.
Br J Urol. 1988 Oct;62(4):352-4. doi: 10.1111/j.1464-410x.1988.tb04364.x.
4
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):468-9. doi: 10.1136/bmj.289.6443.468.
5
Results obtained in the treatment of prostate cancer patients with Zoladex.使用诺雷德治疗前列腺癌患者所获得的结果。
Prog Clin Biol Res. 1985;185A:287-95.
6
A new hormonal therapy for prostatic cancer: long-term clinical and hormonal response.一种用于前列腺癌的新型激素疗法：长期临床及激素反应
Br J Urol. 1986 Oct;58(5):534-8. doi: 10.1111/j.1464-410x.1986.tb05462.x.
7
Long-term effects of buserelin on plasma testosterone and luteinising hormone concentrations.布舍瑞林对血浆睾酮和促黄体生成素浓度的长期影响。
Lancet. 1985 Nov 30;2(8466):1236-7. doi: 10.1016/s0140-6736(85)90758-5.
8
Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.促黄体生成素释放激素类似物ICI 118630（诺雷德）长效制剂用于前列腺癌患者的初步报告。
Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):185-7. doi: 10.1136/bmj.290.6463.185.
9
Antithrombin III concentration, thrombosis, and treatment with luteinising hormone releasing hormone agonist in prostatic carcinoma.抗凝血酶III浓度、血栓形成以及前列腺癌中促黄体生成素释放激素激动剂的治疗
Br Med J (Clin Res Ed). 1986 Apr 5;292(6525):935-6. doi: 10.1136/bmj.292.6525.935.
10
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.不同类型抗雄激素药物对前列腺癌转移患者中促黄体生成素释放激素类似物诱导的睾酮激增的影响。
J Urol. 1990 Oct;144(4):934-41. doi: 10.1016/s0022-5347(17)39625-8.
本文引用的文献
1
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms.
Lancet. 1983 Aug 20;2(8347):415-9. doi: 10.1016/s0140-6736(83)90387-2.
Zotero 插件